January 16 Standards Working Group Agenda

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
Scientific and Medical Accountability Standards Working Group
of the California Institute For Regenerative Medicine
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT 

Date: January 16, 2024
Time: 9:00 am to 12:30 pm

Location: 601 Gateway Blvd., Suite 400
South San Francisco, CA 94080

Public Comment Instructions

 Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:

• Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
• Once we call your name you will have 3 Minutes to make your public comment; please remember to be respectful of the time limit.
• Written comment may be sent to the following email address: mdelatorre@cirm.ca.gov.
• Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location.

YouTube: www.youtube.com/cirmtv

Dial-In information:

Dial in number: (669) 900-6833
Meeting ID: 827 6753 2563
Passcode: 251717

Background Materials:

• INFR7: CIRM Patient Support Program Services
• Community Care Centers of Excellence (CCCE) Concept Plan
• CIRM Scientific and Medical Accountability Standards Working Group Slides

Agenda:

I. Introductions, Meeting Aims and Purpose

II. Session 1: Patient & Community Engagement

The proposed Community Care Centers of Excellence program includes outreach and engagement activities to promote access to clinical trial and treatments arising from CIRM-funded research. The aim of this session is to consider ethics policy guidelines for engagement initiatives to inform program implementation.

III. Session 2: Patient Support for Clinical Trials

CIRM’s Patient Support Program is intended to address the financial and logistical bottlenecks often experienced by patients and their family members enrolling in or participating in CIRM-funded cell and gene therapy trials. The program includes finaical support for patients participating in CIRM-funded trials. The aim of this session is to consider ethics policy guidelines for financial support of clinical research participants, and identify considerations for CIRM program implementation.

IV. Public Comment

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Marivel De La Torre at the California Institute for Regenerative Medicine at (415) 769-8730 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Standards Working Group meeting may be referred to Marivel De La Torre at the California Institute for Regenerative Medicine at mdelatorre@cirm.ca.gov or (415) 769-8730.

 

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

---